Houlihan Capital is pleased to announce the sale of Label Vision Systems, Inc. to Microscan Systems, an operating company in Spectris plc’s (LSE:sxs) Industrial Controls business segment.
Label Vision Systems, Inc. (”LVS”) has developed proprietary software and products that enable label inspection, print inspection, and barcode verification. LVS’s technology, products, and solutions allow companies to inspect barcodes either off-line or in-line, achieving 100% compliance to UDI (Unique Device Identification) and GS1 standards. The company’s products are sold domestically and internationally to the medical device, pharmaceutical and life sciences industries. LVS has recently experienced rapid growth and expects this trend to continue as these companies implement protocols to address the requirements of UDI and e-pedigree / serialization supply chain traceability legislation.
Microscan is a global technology leader in precision data acquisition and control solutions serving a wide range of automation and OEM applications. Founded in 1982, Microscan has a strong history of innovation that includes the invention of the first laser diode barcode scanner and the Data Matrix symbology. Today, Microscan remains a technology leader in automatic identification and machine vision with extensive solutions for ID tracking, traceability, and inspection, ranging from basic barcode reading to complex machine vision inspection, identification, and measurement.
Houlihan Capital represented and advised the management team and owner of LVS as it conducted a comprehensive process to identify and initiate discussions with strategic acquirers that valued LVS’s proprietary technologies, products and customer relationships. LVS had a first mover advantage in a rapidly expanding market segment attracting the attention of larger firms. Management’s goal was to partner with a firm that has the sales, marketing and manufacturing resources to assure that LVS’s technology and products remain the world-wide standard for print inspection and bar code verification for the Life Science industries. For more information contact Joe Lunkes, Managing Director at 312-450-8638 or jlunkes@houlihancapital.com.
Houlihan Capital, a leading boutique professional financial services firm, is SOC-compliant, a Financial Industry Regulatory Authority (FINRA) and SIPC member. Its Valuation and Financial Advisory Group provides portfolio valuations, transaction opinions and a variety of consulting services. The firm’s Investment Banking Group offers sell/buy side advisory, capital raises and secondary market advisory services. Houlihan Capital serves a myriad of clients in a wide array of industries, through an integrated advisory approach that draws upon strategic and technical expertise, industry knowledge, transactional and financing experience, and an expansive network of institutional and private investors to guide management teams and investors. Visit www.houlihancapital.com to learn more.
